Vilip is an oral antidiabetic medicine used in the management of type 2 diabetes mellitus. It works by enhancing the activity of incretin hormones, which help regulate blood glucose levels by increasing insulin secretion and reducing excess glucagon release in a glucose-dependent manner. This dual action supports effective postprandial and fasting blood sugar control, contributing to improved overall glycemic management. Vilip is commonly used as part of a comprehensive treatment plan that includes diet and lifestyle modification, either as monotherapy or in combination with other antidiabetic agents when additional control is required. By maintaining stable blood glucose levels, Vilip helps reduce the risk of long-term diabetes-related complications and supports better metabolic health and quality of life.